Milan, Italy

Gian Carlo Fregnan

This inventor holds 1 USPTO granted patent. Top assignee: Societa' Farmaceutici Italia. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gian Carlo Fregnan. Retrieved from https://idiyas.com/inventor/gian-carlo-fregnan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gian Carlo Fregnan: Innovator in Pharmaceutical Chemistry

Introduction

Gian Carlo Fregnan is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on lumilysergol esters. His research has implications for various therapeutic applications.

Latest Patents

Fregnan holds a patent for "Pyrrole-carboxylic acids lumilysergol esters." This patent describes esters of 1-methyl-lumilysergol-10-methylether, which possess various chemical properties. The compounds exhibit adrenolytic, hypotensive, sedative, and antiserotoninic activities, making them valuable in medical applications. He has 1 patent to his name.

Career Highlights

Gian Carlo Fregnan is associated with Società Farmaceutici Italia S.p.a., where he continues to advance his research. His work has been instrumental in developing new pharmaceutical compounds that can lead to improved treatments for various conditions.

Collaborations

Fregnan has collaborated with notable colleagues, including Luigi Bernardi and Germano Bosisio. These partnerships have fostered a collaborative environment that enhances innovation in their field.

Conclusion

Gian Carlo Fregnan's contributions to pharmaceutical chemistry highlight his role as an innovator. His patent work and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…